Physician profile
Randall E Henderson
NPI 1548269780
$3,974.30
in general payments reported to CMS, 2019-2025
16 companies · $948 in 2025
The $948 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $697 · 2020: $44.38 · 2021: $281 · 2022: $675 · 2023: $653 · 2024: $676 · 2025: $948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,277.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,885.83 | 2019-2025 | |
| Janssen Biotech, INC. | $146.14 | 2025 | Tremfya |
| Merck Sharp & Dohme LLC | $138.47 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $130.63 | 2019-2024 | Entyvio |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Regeneron Healthcare Solutions, INC. | $121.36 | 2024 | Dupixent |
| Medical Device Business Services, INC. | $111.42 | 2019 | |
| Heron Therapeutics, INC. | $106.84 | 2022 | |
| Boston Scientific Corporation | $57.93 | 2025 | General - Endochoice |
| Teleflex LLC | $29.82 | 2021-2023 | Guideliner |
| Dendreon Pharmaceuticals LLC | $24.07 | 2023 | Provenge |
| Actelion Pharmaceuticals US, INC. | $20.29 | 2024 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.94 | 2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.45 | 2019 | |
| Amgen INC. | $18.61 | 2023 | Repatha |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.50 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.